▶Both Andrew Huberman and Stephen Ilardi assert that supplementing with Omega-3s, specifically the EPA component, provides significant benefits for brain health and mental well-being.

▶A therapeutic dose is consistently identified as being over one gram of EPA per day, with recommendations ranging from 1,000 mg to 3,000 mg for various cognitive and antidepressant effects.Feb 2026

▶Both sources reference verified scientific data, including controlled research trials, to support the claims that Omega-3s have antidepressant effects and benefit brain health.Feb 2026

▶There is an underlying agreement that modern diets are deficient in Omega-3s, making supplementation a necessary consideration for optimal health.Feb 2026

▶The primary focus of the benefits differs: Stephen Ilardi's claims concentrate on Omega-3s as an antidepressant and a corrective for the inflammatory modern diet, while Andrew Huberman discusses a broader range of applications including focus, ADHD, and general cognitive performance.

▶While dosage ranges overlap, there are slight differences in emphasis. Ilardi specifies a 1,000-2,000 mg EPA dose for antidepressant effects, whereas Huberman often discusses a higher range up to 3,000 mg for cognitive function.

▶The underlying causal framework varies. Ilardi presents the issue as a 'disease of civilization' stemming from a severe imbalance of Omega-6 to Omega-3 fats compared to ancestral diets. Huberman frames it more as a tool for health and performance optimization in a modern context.

▶The mechanism of action is emphasized differently. Ilardi highlights the anti-inflammatory properties of Omega-3s in contrast to the inflammatory nature of Omega-6s, while Huberman focuses more on their direct role in supporting neuronal structure and function.Feb 2026